News Formal

Johnson & Johnson Fourth-Quarter Earnings Down 25%

  • 📰 WSJhealth
  • ⏱ Reading Time:
  • 12 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 8%
  • Publisher: 53%

Россия Новости Новости

Россия Последние новости,Россия Последние новости

The healthcare-products company reported declining sales in the fourth quarter as demand dropped for its Covid-19 vaccine.

Johnson & Johnson reported a 25% drop in earnings and declining sales for the fourth quarter as demand dropped for its Covid-19 vaccine, while providing a cautious forecast for sales growth as the company undergoes a big transformation.

The New Brunswick, N.J., healthcare-products company said Tuesday that quarterly revenue fell 4.4% to $23.71 billion on fewer vaccine sales and a stronger dollar, below analyst estimates of $23.9 billion, according to FactSet.

 

Спасибо за ваш комментарий. Ваш комментарий будет опубликован после проверки
Мы обобщили эту новость, чтобы вы могли ее быстро прочитать.Если новость вам интересна, вы можете прочитать полный текст здесь Прочитайте больше:

 /  🏆 413. in RU

Россия Последние новости, Россия Последние новости

Similar News:Вы также можете прочитать подобные новости, которые мы собрали из других источников новостей

Microsoft Earnings Likely Slid Last Quarter Amid Economic ConcernsThe software giant likely recorded its slowest sales growth in more than six years last quarter as economic concerns cooled demand for its software and cloud services. That's because they did what was once thought impossible, they released a Windows that was worse than Windows 8. 😬😬😬
Источник: WSJ - 🏆 98. / 63 Прочитайте больше »